These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38190482)

  • 1. Effect of ozone gas on viral kinetics and liver histopathology in hepatitis C patients.
    Sadek A; Abd El Hady AM; Olfat H; Abd El Hady AA; Wafy W; Zaki M; Youness ER
    J Complement Integr Med; 2024 Mar; 21(1):131-138. PubMed ID: 38190482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes of liver fibrosis in chronic hepatitis C patients with no response to interferon-alpha therapy: including quantitative assessment by a morphometric method.
    Yagura M; Murai S; Kojima H; Tokita H; Kamitsukasa H; Harada H
    J Gastroenterol; 2000; 35(2):105-11. PubMed ID: 10680665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver fibrosis and hepatic stellate cells improvement of chronic hepatitis C patients by interferon-beta-1a with or without sustained viral response.
    Rao HY; Wei L; Li J; Zhang LF; Chen HY; Zhu LM; Liu F; Sun Y; Wang H
    Hepatogastroenterology; 2009; 56(90):328-34. PubMed ID: 19579592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of hepatic fibrosis in hepatitis C with long-term interferon treatment.
    Dufour JF; DeLellis R; Kaplan MM
    Dig Dis Sci; 1998 Dec; 43(12):2573-6. PubMed ID: 9881484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms Underlying Hepatitis C Virus-Associated Hepatic Fibrosis.
    Khatun M; Ray RB
    Cells; 2019 Oct; 8(10):. PubMed ID: 31615075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary results of ozone therapy as a possible treatment for patients with chronic hepatitis C.
    Zaky S; Kamel SE; Hassan MS; Sallam NA; Shahata MA; Helal SR; Mahmoud H
    J Altern Complement Med; 2011 Mar; 17(3):259-63. PubMed ID: 21417811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon gamma-1b for the treatment of fibrosis in chronic hepatitis C infection.
    Muir AJ; Sylvestre PB; Rockey DC
    J Viral Hepat; 2006 May; 13(5):322-8. PubMed ID: 16637863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrosis progression in interferon treatment-naive Chinese plasma donors with chronic hepatitis C for 20 years: a cohort study.
    Li JF; Liu S; Ren F; Liu M; Wu HL; Chen Y; Zou HB; Bai L; Li Y; Zheng SJ; Duan ZP
    Int J Infect Dis; 2014 Oct; 27():49-53. PubMed ID: 25168642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon.
    Di Bisceglie AM; Shiffman ML; Everson GT; Lindsay KL; Everhart JE; Wright EC; Lee WM; Lok AS; Bonkovsky HL; Morgan TR; Ghany MG; Morishima C; Snow KK; Dienstag JL;
    N Engl J Med; 2008 Dec; 359(23):2429-41. PubMed ID: 19052125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the treatment of hepatitis C.
    Lawrence SP
    Adv Intern Med; 2000; 45():65-105. PubMed ID: 10635046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term administration of interferon-alpha in non-responder patients with chronic hepatitis C: follow-up of liver fibrosis over 5 years.
    Guerret S; Desmoulière A; Chossegros P; Costa AM; Badid C; Trépo C; Grimaud JA; Chevallier M
    J Viral Hepat; 1999 Mar; 6(2):125-33. PubMed ID: 10607223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic inflammation and progressive liver fibrosis in chronic liver disease.
    Czaja AJ
    World J Gastroenterol; 2014 Mar; 20(10):2515-32. PubMed ID: 24627588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders.
    Nelson DR; Lauwers GY; Lau JY; Davis GL
    Gastroenterology; 2000 Apr; 118(4):655-60. PubMed ID: 10734016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant liver damage in patients with bleeding disorders and chronic hepatitis C: non-invasive assessment of liver fibrosis using transient elastography.
    Posthouwer D; Mauser-Bunschoten EP; Fischer K; VAN Erpecum KJ; DE Knegt RJ
    J Thromb Haemost; 2007 Jan; 5(1):25-30. PubMed ID: 17239163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histological response study of chronic viral hepatitis C patients treated with interferon alone or combined with ribavirin.
    Prado K; Patzina R; Bergamaschi D; Focaccia R
    Braz J Infect Dis; 2008 Oct; 12(5):362-7. PubMed ID: 19219273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in liver histopathology in women infected with hepatitis C through contaminated anti-D immunoglobulin injections in Ireland.
    Albloushi SS; Murray FE; Callagy G; Courtney MG; O'Keane JC; Kay E
    Eur J Gastroenterol Hepatol; 1998 Jan; 10(1):69-73. PubMed ID: 9512956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does mild hepatitis on liver biopsy warrant immediate combination anti viral therapy in chronic hepatitis C patients?
    Khalid SR; Luk NH; Mirza SA; Saeed F; Hashmi SN; Mushtaq S; Tanvir A; Rana WA
    J Ayub Med Coll Abbottabad; 2010; 22(2):1-3. PubMed ID: 21702253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic fibrosis in patients with chronic hepatitis C assessed by transient elastography: implications for determining the efficacy of antiviral therapy.
    Mendoza J; Trapero-Marugán M; González-Moreno L; Jones EA; Gómez-Domínguez E; Moreno-Otero R
    Rev Esp Enferm Dig; 2010 Jul; 102(7):426-34. PubMed ID: 20617863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The spectrum of hepatic functional impairment in compensated chronic hepatitis C: results from the Hepatitis C Anti-viral Long-term Treatment against Cirrhosis Trial.
    Everson GT; Shiffman ML; Morgan TR; Hoefs JC; Sterling RK; Wagner DA; Kulig CC; Curto TM; Wright EC;
    Aliment Pharmacol Ther; 2008 May; 27(9):798-809. PubMed ID: 18266997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of hepatic histopathology in kidney transplant recipients with chronic hepatitis C virus infection and effect of immunosuppression on the course of hepatitis C virus infection.
    Korkmaz M; Fakı S; Öcal S; Harmancı Ö; Selçuk H; Haberal M
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():159-64. PubMed ID: 25894147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.